|Day Low/High||15.35 / 15.49|
|52 Wk Low/High||14.61 / 32.80|
Bayer shares fell after the drugmaker posted solid full-year earnings but said its crop sciences unit would see modest growth in 2017 as it completes its $66 billion Monsanto takeover.
A week full of financial reports continues, as Bayer and Lloyds post full-year earnings
Chemical companies, lumber producers and other sectors that should benefit from capital spending look to do well going forward.
A WWF report shows how fragile our hold on the world's ecology is. Does Asia represent the future of food production?
This is new doctrine having to do with innovation and the stifling of innovation to create new products.
Results have shown that many major "blockbuster" deals aren't blockbuster investments later.
Regulatory issues will weigh on this deal, because of populist politics.
Here is why CBS, Constellation Brands, Monsanto and Aetna will be winners in 2017.
Despite some upgrades, fertilizers still trade like ... well, crap. Meanwhile, Monsanto , the object of Bayer's desire, continues to breakdown -- and is threatening the $100-to-$102 level. I would avoid the space -- it stinks. The recovery in ...
U.S. stocks gained steam on Wednesday, even though oil prices continued to slide.
Bayer has agreed to purchase Monsanto for $66 billion, or $128 a share, a 20% premium over its previous closing price.
Zoetis is not averse to a little noise as investors, analysts take notice.
Bayer increases its latest offering to entice Monsanto, as regulators look closely at agribusiness mergers.
Navistar shares were rallying Tuesday on news of a major stake taken by Volkswagen.
Stocks hold onto gains through the morning session as new home sales hit a nearly eight-year high in July.
U.S. futures were rising across the board on Tuesday while crude prices experienced a decline.
Aetna and Humana each traded down sharply as antitrust hurdles may block $34 billion merger.
A rush of earnings kept investors busy throughout the morning. Netflix was one of the biggest drags on the Nasdaq and S&P 500.
The S&P 500 closed out Thursday's session with its fourth record close in a row as hopes for global monetary stimulus kept hopes high on Wall Street.
U.S. stocks rocketed higher as the fears over rate hikes that have plagued Wall Street for nearly a week began to fade on Tuesday.
I'm selling out of the balance of my long in Potash Corp. (POT) for a small profit in the wake of Bayer (BAYRY) making a $62 billion unsolicited bid today for POT rival Monsanto (MON). I expect the Bayer bid to face antitrust hurdles, and I don't ex...
Monsanto started the agribusiness/chemical merger trend with its pursuit of Syngenta. A year later, consolidation is rampant.
The potential combination of Bayer and Monsanto could be blocked, says Jim Cramer.
The S&P 500 and Dow gave up earlier crude-inspired gains. Crude has traded near $47 a barrel earlier in the session, only to come back to around $46.
Shares of Siemens dropped over 14% in 2015, but a recent earnings report has given the German turbine-maker’s stock a jolt.